glycerol has been researched along with isoxazoles in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ansalone, D; Calvanese, RC; Federico, S; Galzerano, V; Gurrieri, G; Petraglia, A; Scarpitta, M; Zinno, A | 1 |
Kondraciuk, K; Skarzynski, DJ; Woclawek-Potocka, I | 1 |
2 other study(ies) available for glycerol and isoxazoles
Article | Year |
---|---|
Negligible metabolic effects of long-term oral treatment with a new beta 2-agonist: broxaterol.
Topics: Acid-Base Equilibrium; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Airway Obstruction; Blood Glucose; Bronchial Spasm; Cholesterol; Electrolytes; Fatty Acids, Nonesterified; Female; Glycerol; Heart Rate; Humans; Insulin; Isoxazoles; Male; Metabolism; Middle Aged; Respiratory Function Tests; Triglycerides | 1990 |
Lysophosphatidic acid stimulates prostaglandin E2 production in cultured stromal endometrial cells through LPA1 receptor.
Topics: Animals; Calcium Signaling; Cattle; Cell Survival; Cells, Cultured; Cyclooxygenase 2; Dinoprost; Dinoprostone; Diphosphates; Endometrium; Epithelial Cells; Female; Glycerol; Intracellular Space; Intramolecular Oxidoreductases; Isoxazoles; Lysophospholipids; Propionates; Prostaglandin-E Synthases; Receptors, Lysophosphatidic Acid; RNA, Messenger; Stromal Cells | 2009 |